{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:59:18Z","timestamp":1781528358976,"version":"3.54.1"},"reference-count":60,"publisher":"Harborside Press, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Surgical stabilization followed by postoperative radiotherapy (RT) is the standard of care for impending pathologic fractures due to bone metastases. Compared with conventional RT, stereotactic body RT (SBRT) provides more durable tumor control and palliation, but treatment volume constraints often preclude postoperative use. Preoperative SBRT limited to the tumor volume offers a solution by delivering an ablative dose before intraoperative tumor dissemination, but its safety is not established.\n                    <jats:bold>Methods:<\/jats:bold>\n                    We conducted a phase I, nonrandomized clinical trial at a quaternary care cancer center, with accrual between June 2021 and April 2024. Eligible patients (N=38) had pelvic or long bone metastases with impending pathologic fractures requiring surgical stabilization. Patients received preoperative SBRT (27\u201330 Gy in 3 fractions or 18\u201324 Gy in 1 fraction) followed by surgical stabilization within 1 week. The primary endpoint was rate of wound complications within 6 weeks after preoperative SBRT and surgical stabilization. Secondary endpoints were rates of tumor recurrence and grade \u22653 treatment-related toxicities within 1 year.\n                    <jats:bold>Results:<\/jats:bold>\n                    A total of 7 patients were excluded due to inability to receive treatment or death prior to the primary endpoint. Thirty-one patients were evaluated at 6 weeks postoperatively, 26 at 3 months, and 16 at 1 year. The median age was 66 years (IQR, 59\u201371), and 15 (48%) patients were male. At 6 weeks, 2 of 31 patients (6.5%; 95% CI, 0.79\u201321.4) experienced wound complications. At 3 months, 1 of 26 patients (3.8%; 95% CI, 0.10\u201319.6) experienced grade \u22653 treatment-related toxicity. At 12 months, 1 of 16 patients (6.3%; 95% CI, 0.16\u201330.2) had tumor recurrence.\n                    <jats:bold>Conclusions:<\/jats:bold>\n                    Preoperative SBRT is associated with a low risk of wound complications and durable local tumor control. A randomized controlled trial examining its efficacy, potential to facilitate less invasive surgery, and impact on functional outcomes is warranted.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>ClinicalTrials.gov identifier:<\/jats:bold>\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05038124?term=NCT05038124&amp;draw=2&amp;rank=1\">NCT05038124<\/jats:ext-link>\n                  <\/jats:p>","DOI":"10.6004\/jnccn.2025.7478","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T15:20:21Z","timestamp":1778599221000},"page":"265-270","source":"Crossref","is-referenced-by-count":0,"title":["Preoperative Stereotactic Body Radiotherapy for Metastatic Bone Disease With Impending Fracture: A Nonrandomized Clinical Trial"],"prefix":"10.6004","volume":"24","author":[{"given":"Max","family":"Vaynrub","sequence":"first","affiliation":[{"name":"Department of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith K.","family":"Bartelstein","sequence":"additional","affiliation":[{"name":"Department of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Y.","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"Gomez","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Prince","sequence":"additional","affiliation":[{"name":"Department of Surgery, Orthopaedic Service, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Lobaugh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris A.","family":"Mueller","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Bernstein","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Guttmann","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Yerramilli","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan T.","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY"},{"name":"Department of Radiation Oncology, New York University Langone Health, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4047","reference":[{"key":"B1","series-title":"Nat Rev Cancer","first-page":"584","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy GR","year":"2002","unstructured":"Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584\u2013593."},{"key":"B2","article-title":"NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain. Version 2","author":"Swarm RA","year":"2025","unstructured":"Swarm RA, Youngwerth JM, Agne JL,  NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain. Version 2.2025. Accessed January 5, 2026. To view the most recent version, visit https:\/\/www.nccn.org"},{"key":"B3","article-title":"NCCN Clinical Practice Guidelines in Oncology: Palliative Care. Version 1","author":"Walling AM","year":"2026","unstructured":"Walling AM, Campbell T, Agarwal R,  NCCN Clinical Practice Guidelines in Oncology: Palliative Care. Version 1.2026. Accessed January 5, 2026. To view the most recent version, visit https:\/\/www.nccn.org"},{"key":"B4","series-title":"Pract Radiat Oncol","first-page":"4","article-title":"Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline","volume":"7","author":"Lutz S","year":"2017","unstructured":"Lutz S, Balboni T, Jones J,  Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol 2017;7:4\u201312."},{"key":"B5","series-title":"Pract Radiat Oncol","first-page":"349","article-title":"Choosing wisely: the American Society for Radiation Oncology\u2019s top 5 list","volume":"4","author":"Hahn C","year":"2014","unstructured":"Hahn C, Kavanagh B, Bhatnagar A,  Choosing wisely: the American Society for Radiation Oncology\u2019s top 5 list. Pract Radiat Oncol 2014;4:349\u2013355."},{"key":"B6","series-title":"J Natl Cancer Inst","first-page":"798","article-title":"Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases","volume":"97","author":"Hartsell WF","year":"2005","unstructured":"Hartsell WF, Scott CB, Bruner DW,  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005;97:798\u2013804."},{"key":"B7","series-title":"Pract Radiat Oncol","first-page":"76","article-title":"RTOG 0631 phase 2\/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results","volume":"4","author":"Ryu S","year":"2014","unstructured":"Ryu S, Pugh SL, Gerszten PC,  RTOG 0631 phase 2\/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol 2014;4:76\u201381."},{"key":"B8","series-title":"Int J Radiat Oncol Biol Phys","first-page":"965","article-title":"Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline","volume":"79","author":"Lutz S","year":"2011","unstructured":"Lutz S, Berk L, Chang E,  Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011;79:965\u2013976."},{"key":"B9","series-title":"J Clin Oncol","first-page":"2345","article-title":"Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease","volume":"12","author":"Townsend PW","year":"1994","unstructured":"Townsend PW, Rosenthal HG, Smalley SR,  Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol 1994;12:2345\u20132350."},{"key":"B10","series-title":"Pract Radiat Oncol","first-page":"e531","article-title":"Postoperative radiation therapy for osseous metastasis: outcomes and predictors of local failure","volume":"5","author":"Epstein-Peterson ZD","year":"2015","unstructured":"Epstein-Peterson ZD, Sullivan A, Krishnan M,  Postoperative radiation therapy for osseous metastasis: outcomes and predictors of local failure. Pract Radiat Oncol 2015;5:e531\u2013536."},{"key":"B11","series-title":"Adv Radiat Oncol","first-page":"100756","article-title":"Should postoperative radiation for long bone metastases cover part or all of the orthopedic hardware? Results of a large retrospective analysis","volume":"6","author":"Rosen DB","year":"2021","unstructured":"Rosen DB, Haseltine JM, Bartelstein M,  Should postoperative radiation for long bone metastases cover part or all of the orthopedic hardware? Results of a large retrospective analysis. Adv Radiat Oncol 2021;6:100756."},{"key":"B12","series-title":"JAMA Oncol","first-page":"872","article-title":"Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: a randomized phase 2 trial","volume":"5","author":"Nguyen QN","year":"2019","unstructured":"Nguyen QN, Chun SG, Chow E,  Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: a randomized phase 2 trial. JAMA Oncol 2019;5:872\u2013878."},{"key":"B13","series-title":"Ann Palliat Med","first-page":"58","article-title":"Stereotactic body radiation therapy for non-spine bone metastases\u2014a review of the literature","volume":"5","author":"Bedard G","year":"2016","unstructured":"Bedard G, McDonald R, Poon I,  Stereotactic body radiation therapy for non-spine bone metastases\u2014a review of the literature. Ann Palliat Med 2016;5:58\u201366."},{"key":"B14","series-title":"Radiother Oncol","first-page":"304","article-title":"Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases","volume":"127","author":"Erler D","year":"2018","unstructured":"Erler D, Brotherston D, Sahgal A,  Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases. Radiother Oncol 2018;127:304\u2013309."},{"key":"B15","series-title":"Lancet","first-page":"2235","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial","volume":"359","author":"O\u2019Sullivan B","year":"2002","unstructured":"O\u2019Sullivan B, Davis AM, Turcotte R,  Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359:2235\u20132241."},{"key":"B16","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1595","article-title":"Preoperative and postoperative irradiation of soft tissue sarcomas: effect on radiation field size","volume":"21","author":"Nielsen OS","year":"1991","unstructured":"Nielsen OS, Cummings B, O\u2019Sullivan B,  Preoperative and postoperative irradiation of soft tissue sarcomas: effect on radiation field size. Int J Radiat Oncol Biol Phys 1991;21:1595\u20131599."},{"key":"B17","series-title":"Phys Med Biol","first-page":"3295","article-title":"Dose perturbation in the presence of metallic implants: treatment planning system versus Monte Carlo simulations","volume":"48","author":"Wieslander E","year":"2003","unstructured":"Wieslander E, Kn\u00f6\u00f6s T. Dose perturbation in the presence of metallic implants: treatment planning system versus Monte Carlo simulations. Phys Med Biol 2003;48:3295\u20133305."},{"key":"B18","series-title":"Phys Med Biol","first-page":"6733","article-title":"Effect of spine hardware on small spinal stereotactic radiosurgery dosimetry","volume":"58","author":"Wang X","year":"2013","unstructured":"Wang X, Yang JN, Li X,  Effect of spine hardware on small spinal stereotactic radiosurgery dosimetry. Phys Med Biol 2013;58:6733\u20136747."},{"key":"B19","series-title":". Clin Orthop Relat Res","first-page":"256","article-title":"Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures","volume":"249","author":"Mirels H","year":"1989","unstructured":"Mirels H. Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 1989;249:256\u2013264."},{"key":"B20","series-title":"Control Clin Trials","first-page":"1","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon R","year":"1989","unstructured":"Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989;10:1\u201310."},{"key":"B21","series-title":"J Neurosurg Spine","first-page":"411","article-title":"No association between excessive wound complications and preoperative high-dose, hypofractionated, image-guided radiation therapy for spine metastasis","volume":"20","author":"Keam J","year":"2014","unstructured":"Keam J, Bilsky MH, Laufer I,  No association between excessive wound complications and preoperative high-dose, hypofractionated, image-guided radiation therapy for spine metastasis. J Neurosurg Spine 2014;20:411\u2013420."},{"key":"B22","series-title":"Radiat Oncol","first-page":"153","article-title":"Risk for surgical complications after previous stereotactic body radiotherapy of the spine","volume":"12","author":"Roesch J","year":"2017","unstructured":"Roesch J, Cho JBC, Fahim DK,  Risk for surgical complications after previous stereotactic body radiotherapy of the spine. Radiat Oncol 2017;12:153."},{"key":"B23","series-title":"Acta Oncol","first-page":"251","article-title":"Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study","volume":"58","author":"Versteeg AL","year":"2019","unstructured":"Versteeg AL, Hes J, van der Velden JM,  Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study. Acta Oncol 2019;58:251\u2013256."},{"key":"B24","series-title":"Front Oncol","first-page":"626","article-title":"Stereotactic radiotherapy followed by surgical stabilization within 24 h for unstable spinal metastases; a stage I\/IIa study according to the IDEAL framework","volume":"8","author":"Versteeg AL","year":"2018","unstructured":"Versteeg AL, van der Velden JM, Hes J,  Stereotactic radiotherapy followed by surgical stabilization within 24 h for unstable spinal metastases; a stage I\/IIa study according to the IDEAL framework. Front Oncol 2018;8:626."},{"key":"B25","series-title":"Neurosurgery","first-page":"199","article-title":"Hybrid therapy (surgery and radiosurgery) for the treatment of renal cell carcinoma spinal metastases","volume":"90","author":"Hussain I","year":"2022","unstructured":"Hussain I, Goldberg JL, Carnevale JA,  Hybrid therapy (surgery and radiosurgery) for the treatment of renal cell carcinoma spinal metastases. Neurosurgery 2022;90:199\u2013206."},{"key":"B26","series-title":"Int J Radiat Oncol Biol Phys","first-page":"829","article-title":"Histologic classifier of radiosensitivity to spine stereotactic body radiation therapy","volume":"123","author":"Jackson CB","year":"2025","unstructured":"Jackson CB, Boe LA, Zhang L,  Histologic classifier of radiosensitivity to spine stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2025;123:829\u2013838."},{"key":"B27","series-title":"Acta Oncol","first-page":"584","article-title":"A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases","volume":"51","author":"Jhaveri PM","year":"2012","unstructured":"Jhaveri PM, Teh BS, Paulino AC,  A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases. Acta Oncol 2012;51:584\u2013588."},{"key":"B28","series-title":"Int J Radiat Oncol Biol Phys","first-page":"672","article-title":"Phase 3 multi-center, prospective, randomized trial comparing single-dose 24 Gy radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic cancer","volume":"110","author":"Zelefsky MJ","year":"2021","unstructured":"Zelefsky MJ, Yamada Y, Greco C,  Phase 3 multi-center, prospective, randomized trial comparing single-dose 24 Gy radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic cancer. Int J Radiat Oncol Biol Phys 2021;110:672\u2013679."},{"key":"B29","series-title":"Oncologist","first-page":"1227","article-title":"Radiation recall with anticancer agents","volume":"15","author":"Burris HA","year":"2010","unstructured":"Burris HA, Hurtig J. Radiation recall with anticancer agents. Oncologist 2010;15:1227\u20131237."},{"key":"B30","series-title":"Clin Orthop Relat Res","first-page":"2000","article-title":"Trends in the surgical treatment of pathologic proximal femur fractures among Musculoskeletal Tumor Society members","volume":"471","author":"Steensma M","year":"2013","unstructured":"Steensma M, Healey JH. Trends in the surgical treatment of pathologic proximal femur fractures among Musculoskeletal Tumor Society members. Clin Orthop Relat Res 2013;471:2000\u20132006."},{"key":"B1","series-title":"Nat Rev Cancer","first-page":"584","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy GR","year":"2002","unstructured":"Mundy GR. Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2:584\u2013593."},{"key":"B2","article-title":"NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain. Version 2","author":"Swarm RA","year":"2025","unstructured":"Swarm RA, Youngwerth JM, Agne JL,  NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain. Version 2.2025. Accessed January 5, 2026. To view the most recent version, visit https:\/\/www.nccn.org"},{"key":"B3","article-title":"NCCN Clinical Practice Guidelines in Oncology: Palliative Care. Version 1","author":"Walling AM","year":"2026","unstructured":"Walling AM, Campbell T, Agarwal R,  NCCN Clinical Practice Guidelines in Oncology: Palliative Care. Version 1.2026. Accessed January 5, 2026. To view the most recent version, visit https:\/\/www.nccn.org"},{"key":"B4","series-title":"Pract Radiat Oncol","first-page":"4","article-title":"Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline","volume":"7","author":"Lutz S","year":"2017","unstructured":"Lutz S, Balboni T, Jones J,  Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol 2017;7:4\u201312."},{"key":"B5","series-title":"Pract Radiat Oncol","first-page":"349","article-title":"Choosing wisely: the American Society for Radiation Oncology\u2019s top 5 list","volume":"4","author":"Hahn C","year":"2014","unstructured":"Hahn C, Kavanagh B, Bhatnagar A,  Choosing wisely: the American Society for Radiation Oncology\u2019s top 5 list. Pract Radiat Oncol 2014;4:349\u2013355."},{"key":"B6","series-title":"J Natl Cancer Inst","first-page":"798","article-title":"Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases","volume":"97","author":"Hartsell WF","year":"2005","unstructured":"Hartsell WF, Scott CB, Bruner DW,  Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005;97:798\u2013804."},{"key":"B7","series-title":"Pract Radiat Oncol","first-page":"76","article-title":"RTOG 0631 phase 2\/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results","volume":"4","author":"Ryu S","year":"2014","unstructured":"Ryu S, Pugh SL, Gerszten PC,  RTOG 0631 phase 2\/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. Pract Radiat Oncol 2014;4:76\u201381."},{"key":"B8","series-title":"Int J Radiat Oncol Biol Phys","first-page":"965","article-title":"Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline","volume":"79","author":"Lutz S","year":"2011","unstructured":"Lutz S, Berk L, Chang E,  Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline. Int J Radiat Oncol Biol Phys 2011;79:965\u2013976."},{"key":"B9","series-title":"J Clin Oncol","first-page":"2345","article-title":"Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease","volume":"12","author":"Townsend PW","year":"1994","unstructured":"Townsend PW, Rosenthal HG, Smalley SR,  Impact of postoperative radiation therapy and other perioperative factors on outcome after orthopedic stabilization of impending or pathologic fractures due to metastatic disease. J Clin Oncol 1994;12:2345\u20132350."},{"key":"B10","series-title":"Pract Radiat Oncol","first-page":"e531","article-title":"Postoperative radiation therapy for osseous metastasis: outcomes and predictors of local failure","volume":"5","author":"Epstein-Peterson ZD","year":"2015","unstructured":"Epstein-Peterson ZD, Sullivan A, Krishnan M,  Postoperative radiation therapy for osseous metastasis: outcomes and predictors of local failure. Pract Radiat Oncol 2015;5:e531\u2013536."},{"key":"B11","series-title":"Adv Radiat Oncol","first-page":"100756","article-title":"Should postoperative radiation for long bone metastases cover part or all of the orthopedic hardware? Results of a large retrospective analysis","volume":"6","author":"Rosen DB","year":"2021","unstructured":"Rosen DB, Haseltine JM, Bartelstein M,  Should postoperative radiation for long bone metastases cover part or all of the orthopedic hardware? Results of a large retrospective analysis. Adv Radiat Oncol 2021;6:100756."},{"key":"B12","series-title":"JAMA Oncol","first-page":"872","article-title":"Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: a randomized phase 2 trial","volume":"5","author":"Nguyen QN","year":"2019","unstructured":"Nguyen QN, Chun SG, Chow E,  Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: a randomized phase 2 trial. JAMA Oncol 2019;5:872\u2013878."},{"key":"B13","series-title":"Ann Palliat Med","first-page":"58","article-title":"Stereotactic body radiation therapy for non-spine bone metastases\u2014a review of the literature","volume":"5","author":"Bedard G","year":"2016","unstructured":"Bedard G, McDonald R, Poon I,  Stereotactic body radiation therapy for non-spine bone metastases\u2014a review of the literature. Ann Palliat Med 2016;5:58\u201366."},{"key":"B14","series-title":"Radiother Oncol","first-page":"304","article-title":"Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases","volume":"127","author":"Erler D","year":"2018","unstructured":"Erler D, Brotherston D, Sahgal A,  Local control and fracture risk following stereotactic body radiation therapy for non-spine bone metastases. Radiother Oncol 2018;127:304\u2013309."},{"key":"B15","series-title":"Lancet","first-page":"2235","article-title":"Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial","volume":"359","author":"O\u2019Sullivan B","year":"2002","unstructured":"O\u2019Sullivan B, Davis AM, Turcotte R,  Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 2002;359:2235\u20132241."},{"key":"B16","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1595","article-title":"Preoperative and postoperative irradiation of soft tissue sarcomas: effect on radiation field size","volume":"21","author":"Nielsen OS","year":"1991","unstructured":"Nielsen OS, Cummings B, O\u2019Sullivan B,  Preoperative and postoperative irradiation of soft tissue sarcomas: effect on radiation field size. Int J Radiat Oncol Biol Phys 1991;21:1595\u20131599."},{"key":"B17","series-title":"Phys Med Biol","first-page":"3295","article-title":"Dose perturbation in the presence of metallic implants: treatment planning system versus Monte Carlo simulations","volume":"48","author":"Wieslander E","year":"2003","unstructured":"Wieslander E, Kn\u00f6\u00f6s T. Dose perturbation in the presence of metallic implants: treatment planning system versus Monte Carlo simulations. Phys Med Biol 2003;48:3295\u20133305."},{"key":"B18","series-title":"Phys Med Biol","first-page":"6733","article-title":"Effect of spine hardware on small spinal stereotactic radiosurgery dosimetry","volume":"58","author":"Wang X","year":"2013","unstructured":"Wang X, Yang JN, Li X,  Effect of spine hardware on small spinal stereotactic radiosurgery dosimetry. Phys Med Biol 2013;58:6733\u20136747."},{"key":"B19","series-title":". Clin Orthop Relat Res","first-page":"256","article-title":"Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures","volume":"249","author":"Mirels H","year":"1989","unstructured":"Mirels H. Metastatic disease in long bones: a proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res 1989;249:256\u2013264."},{"key":"B20","series-title":"Control Clin Trials","first-page":"1","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon R","year":"1989","unstructured":"Simon R. Optimal two-stage designs for phase II clinical trials. Control Clin Trials 1989;10:1\u201310."},{"key":"B21","series-title":"J Neurosurg Spine","first-page":"411","article-title":"No association between excessive wound complications and preoperative high-dose, hypofractionated, image-guided radiation therapy for spine metastasis","volume":"20","author":"Keam J","year":"2014","unstructured":"Keam J, Bilsky MH, Laufer I,  No association between excessive wound complications and preoperative high-dose, hypofractionated, image-guided radiation therapy for spine metastasis. J Neurosurg Spine 2014;20:411\u2013420."},{"key":"B22","series-title":"Radiat Oncol","first-page":"153","article-title":"Risk for surgical complications after previous stereotactic body radiotherapy of the spine","volume":"12","author":"Roesch J","year":"2017","unstructured":"Roesch J, Cho JBC, Fahim DK,  Risk for surgical complications after previous stereotactic body radiotherapy of the spine. Radiat Oncol 2017;12:153."},{"key":"B23","series-title":"Acta Oncol","first-page":"251","article-title":"Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study","volume":"58","author":"Versteeg AL","year":"2019","unstructured":"Versteeg AL, Hes J, van der Velden JM,  Sparing the surgical area with stereotactic body radiotherapy for combined treatment of spinal metastases: a treatment planning study. Acta Oncol 2019;58:251\u2013256."},{"key":"B24","series-title":"Front Oncol","first-page":"626","article-title":"Stereotactic radiotherapy followed by surgical stabilization within 24 h for unstable spinal metastases; a stage I\/IIa study according to the IDEAL framework","volume":"8","author":"Versteeg AL","year":"2018","unstructured":"Versteeg AL, van der Velden JM, Hes J,  Stereotactic radiotherapy followed by surgical stabilization within 24 h for unstable spinal metastases; a stage I\/IIa study according to the IDEAL framework. Front Oncol 2018;8:626."},{"key":"B25","series-title":"Neurosurgery","first-page":"199","article-title":"Hybrid therapy (surgery and radiosurgery) for the treatment of renal cell carcinoma spinal metastases","volume":"90","author":"Hussain I","year":"2022","unstructured":"Hussain I, Goldberg JL, Carnevale JA,  Hybrid therapy (surgery and radiosurgery) for the treatment of renal cell carcinoma spinal metastases. Neurosurgery 2022;90:199\u2013206."},{"key":"B26","series-title":"Int J Radiat Oncol Biol Phys","first-page":"829","article-title":"Histologic classifier of radiosensitivity to spine stereotactic body radiation therapy","volume":"123","author":"Jackson CB","year":"2025","unstructured":"Jackson CB, Boe LA, Zhang L,  Histologic classifier of radiosensitivity to spine stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2025;123:829\u2013838."},{"key":"B27","series-title":"Acta Oncol","first-page":"584","article-title":"A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases","volume":"51","author":"Jhaveri PM","year":"2012","unstructured":"Jhaveri PM, Teh BS, Paulino AC,  A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases. Acta Oncol 2012;51:584\u2013588."},{"key":"B28","series-title":"Int J Radiat Oncol Biol Phys","first-page":"672","article-title":"Phase 3 multi-center, prospective, randomized trial comparing single-dose 24 Gy radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic cancer","volume":"110","author":"Zelefsky MJ","year":"2021","unstructured":"Zelefsky MJ, Yamada Y, Greco C,  Phase 3 multi-center, prospective, randomized trial comparing single-dose 24 Gy radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic cancer. Int J Radiat Oncol Biol Phys 2021;110:672\u2013679."},{"key":"B29","series-title":"Oncologist","first-page":"1227","article-title":"Radiation recall with anticancer agents","volume":"15","author":"Burris HA","year":"2010","unstructured":"Burris HA, Hurtig J. Radiation recall with anticancer agents. Oncologist 2010;15:1227\u20131237."},{"key":"B30","series-title":"Clin Orthop Relat Res","first-page":"2000","article-title":"Trends in the surgical treatment of pathologic proximal femur fractures among Musculoskeletal Tumor Society members","volume":"471","author":"Steensma M","year":"2013","unstructured":"Steensma M, Healey JH. Trends in the surgical treatment of pathologic proximal femur fractures among Musculoskeletal Tumor Society members. Clin Orthop Relat Res 2013;471:2000\u20132006."}],"container-title":["Journal of the National Comprehensive Cancer Network"],"original-title":[],"link":[{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/24\/6\/article-p265.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/24\/6\/article-p265.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jnccn.org\/downloadpdf\/journals\/jnccn\/24\/6\/article-p265.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:48:00Z","timestamp":1781527680000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnccn.org\/view\/journals\/jnccn\/24\/6\/article-p265.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":60,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.6004\/jnccn.2025.7478","relation":{},"ISSN":["1540-1405","1540-1413"],"issn-type":[{"value":"1540-1405","type":"print"},{"value":"1540-1413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}